The biochemical markers in diagnostic of neuroendocrine tumors
Kushlinskiĭ, N.E.; Liubimova, N.V.
Klinicheskaia Laboratornaia Diagnostika 59(7): 4-11
2014
ISSN/ISBN: 0869-2084 PMID: 25346980 Document Number: 674431
The review considers common concepts of neuroendocrine tumors. The results of original studies of biochemical markers of this type of tumor are presented. The various clinical symptoms and syndromes related to hyper-production of biologically active compounds are described. The characteristic of the most important biochemical markers in diagnostic and monitoring of effectiveness of treatment of neuroendocrine tumors is given.
Document emailed within 1 workday
Related Documents
Kos-Kudła, B. 2006: Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET) Endokrynologia Polska 57(3): 267-272Gazdar, A.F.; Helman, L.J.; Israel, M.A.; Russell, E.K.; Linnoila, R.I.; Mulshine, J.L.; Schuller, H.M.; Park, J.G. 1988: Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin Cancer Research 48(14): 4078-4082
Kizawa, I.; Kikuchi, Y.; Kato, K. 1983: Diagnostic value of biochemical tumor markers in serum of patients with cancer of the ovary Nihon Sanka Fujinka Gakkai Zasshi 35(3): 251-258
Bononi, M.; De Cesare, A.; Atella, F.; Angelini, M.; Graziano, P.; Piat, G. 1998: Neuroendocrine tumors of the gastroenteric canal. Anatomopathological and diagnostic-therapeutic definition. Description of a case with a rare cecal localisation Panminerva Medica 40(2): 146-153
Klöppel, G. 1986: Crucial diagnostic points of tumor markers: gastrointestinal tumors Verhandlungen der Deutschen Gesellschaft für Pathologie 70: 159-171
Yamauchi, M. 2009: Biochemical markers of bone turnover. new aspect. Biochemical bone markers of bone in patients treated with glucocorticoid Clinical Calcium 19(8): 1092-1100
Kanoh, Y. 2011: Biochemical markers and physiological tests of atherosclerosis--changes and usefulness of markers in anti-atherosclerotic therapy Rinsho Byori. Japanese Journal of Clinical Pathology 59(1): 80-88
Yasufuku-Takano, J.; Takano, K. 2011: Pathogenesis and molecular genetics of carcinoid tumors/gastrointestinal neuroendocrine tumors Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 2): 629-634
Weber, M. 2014: New directions in the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): shifting from symptom management to targeting tumors Clinical Advances in Hematology and Oncology: H&o 12(12 Suppl 19: 12-17
Rydzewska, G.; Cichocki, A.; Cwikła, Jław.; Kos-Kudła, B.; Krzyzanowska-Swiniarska, B.; Nasierowska-Guttmejer, A.; Szawłowski, A.; Tomaszewska, R.A.; Bar-Andziak, E.; Bolanowski, M.; Dzielicki, J.; Falconi, M.; Foltyn, W.; Gaciong, Z.; de Herder, W.; Hubalewska-Dydejczyk, A.; Jarzab, B.; Jeziorski, A.; Kowalska, A.; Królicki, L.; Kryszałowicz, B.; Kvols, L.; O'Toole, D.; Kunikowska, J.; Lampe, Pł.; Matyja, V.; Mełen-Mucha, G.; Milewicz, A.; Nowak, A.; Nowakowska-Duława, E.; Omyła-Staszewska, J.; Pajak, J.; Rudzki, Sławomir.; Sowinski, J.; Starzynska, T.; Strzelcz 2008: Endocrine tumors of the stomach and duodenum (including gastrinoma) - management guidelines (recommended by the Polish Network of Neuroendocrine Tumors) Endokrynologia Polska 59(1): 57-67
Yamada, K.; Ogata, S.; Nozaki, R. 2011: Surgical treatment for carcinoid tumors (neuroendocrine tumors) Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 2): 652-655
Sano, T. 2011: Pathology of carcinoid tumors (neuroendocrine tumors) Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 2): 639-642
Khalifa, A.; Mady, E.A.; Abadeer, N.; Kamal, A. 1999: Differential tumor markers and hepatitis markers profile in liver tumors Anticancer Research 19(4a): 2495-2500
Kuroda, I.; Ueno, M. 2009: Biochemical markers of bone turnover. new aspect. Bone metabolic markers in prostatic carcinoma Clinical Calcium 19(8): 1170-1177
Morrison, B.W.; Leder, P. 1994: neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors Oncogene 9(12): 3417-3426
Bours, A.F.; Jorion, J.L.; Donnay, M.; Ledent, G.; Van Ruyssevelt, C. 1993: Neuroendocrine tumors of the prostate Acta Urologica Belgica 61(3): 13-16
Varshney, S.; Johnson, C.D. 2000: Neuroendocrine tumors of the pancreas Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 19(4): 181-183
Delcore, R.; Friesen, S.R. 1994: Gastrointestinal neuroendocrine tumors Journal of the American College of Surgeons 178(2): 187-211
Colombato, L.O. 1995: Neuroendocrine tumors of the digestive tract Acta Gastroenterologica Latinoamericana 25(1): 49-51
Sano, T.; Vrontakis, M.E.; Kovacs, K.; Asa, S.L.; Friesen, H.G. 1991: Galanin immunoreactivity in neuroendocrine tumors Archives of Pathology and Laboratory Medicine 115(9): 926-929